Skip to main content
All lobbying filings

WINNING STRATEGIES WASHINGTON

Lobbying for KALEO · Pharmaceutical development and manufacturing

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 17, 2025
Income
$10,000.00
What the client paid this registrant for the period.
Client based in
Virginia

Official filing document

 Lobbyists on this filing 3
  • ROBERT ZUCKER
    Previously held: LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg
  • CHELSEY PENROD HICKMAN
    Previously held: CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
  • CHARLA PENN
    Previously held: LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 5
Health Issues

Legislation related to prescription drug prices, access to epinephrine in schools, childcare, and other community settings

Pharmacy

Pharmaceutical drug development, including epinephrine for anaphylaxis; drug access and affordability issues

Defense

Medical countermeasures research and development

Budget/Appropriations

Medical countermeasures research and development

Aviation/Airlines/Airports

FAA reauthorization provisions related to emergency medicine.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem